14.24
+0(+0.00%)
Currency In EUR
Sector
Healthcare
Industry
Medical - Equipment & Services
Employees
472
First IPO Date
November 07, 2017
| Name | Title | Pay | Year Born |
| Mr. Matthias Gaertner | Chief Executive Officer & Chairman of the Executive Board | 647,000 | 1967 |
| Dr. Yann Samson | Chairman of Supervisory Board & Sustainability Officer | 90,000 | 1973 |
| Mr. Falk Neukirch | Chief Financial Officer & Member of Executive Board | 565,000 | 1971 |
| Mr. Constantijn van Rietschoten | Chief of International Markets & Member of Executive Board | 568,500 | 1970 |
| Mr. Christoph Prußeit | Chief Innovation Officer & Member of Executive Board | 573,000 | 1988 |
| Ms. Mi-Young Miehler | Chief Operating Officer & Member of Executive Board | 573,000 | 1969 |
| Claudia Nickolaus | Head of Investor & Public Relations | 0 | N/A |
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
